Teva has new Ajovya nalyses and latest Copaxone Data
Teva will present new data on Ajovy and on the long-term safety and efficacy of Copaxone at at the 6th Congress of the European Academy of Neurology
Pharmaceuticals, Biotechnology and Life Sciences
Teva will present new data on Ajovy and on the long-term safety and efficacy of Copaxone at at the 6th Congress of the European Academy of Neurology
Indica Labs and Octo have announced online COVID Digital Pathology Repository (COVID-DPR), a virtual collection of high resolution microscopic COVID-related human tissue images hosted at the National Institutes of Health.
EDIT: Juvenescence put out a press release in error on May 21st, and it has been removed.
BURLINGTON, Mass.–(BUSINESS WIRE)–$SCPH #FUROSCIX–scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential…
Virpax Pharmaceuticals has successfully completed a pre-Investigational New Drug (IND) Application meeting with the U.S. Food and Drug Administration (FDA)…
Thomas J. Schall, Ph.D., President and Chief Executive Officer of ChemoCentryx, said that the company will release topline data from the LUMINA-2 study of CCX140.
Moderna said that after two doses all participants evaluated to date across the 25 µg and 100 µg dose cohorts…
Leinco Technologies and Vanderbilt University Medical Center (VUMC) have agreed to scale up production of its most promising antibodies for development of a rapid, point of care COVID-19 diagnostic test.
Alvotech has named Tanya Zharov as deputy chief executive officer in Iceland to oversee Icelandic operations and administration, including the Reykjavik site leadership team, human resources, business operations, shared services and facilities.
– Tecentriq’s fourth indication in metastatic non-small cell lung cancer and fifth indication in lung cancer overall – – Approval…